|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| A61K 31/506 | |||
| A61P 35/00 | |||
| A61P 31/12 |
| (11) | Number of the document | 2903979 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13843995.5 |
| Date of filing the European patent application | 2013-10-04 | |
| (97) | Date of publication of the European application | 2015-08-12 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/063560 |
| Date | 2013-10-04 |
| (87) | Number | WO 2014/055938 |
| Date | 2014-04-10 |
| (30) | Number | Date | Country code |
| 201261709704 P | 2012-10-04 | US |
| (72) |
DEOKAR, Rhushikesh, Chandrabhan, IN
DUGAR, Sundeep, US
MAHAJAN, Dinesh, IN
WERNER, Milton, Henry, US
|
| (73) |
Sphaera Pharma Pte. Ltd,
8 Temasek Boulevard 22-03 Suntec Tower 3, Singapore 038988,
SG
Inhibikase Therapeutics, Inc., 3350 Riverwood Parkway Suite 1927, Atlanta, GA 30339, US |
| (54) | NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES |
| NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES |